Stefania Capone

9PUBLICATIONS
64CO-AUTHORS
Animal protection (incl. pests and pathogens)Agricultural molecular engineering of nucleic acids and proteinsNanotoxicology, health and safetyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 11, 2023
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates.

Juan I Moliva, Shayne F Andrew, Barbara J Flynn

|Sep 24, 2022
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results.

Chiara Agrati, Concetta Castilletti, Simone Battella

|Oct 26, 2021
GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults.

Simone Lanini, Stefania Capone, Andrea Antinori

|Sep 29, 2021
Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination.

Elena Woods, Vanessa Zaiatz-Bittencourt, Ciaran Bannan

Pageof 2